Skip to main content
SpringerLink
Log in

Patients with early breast cancer benefit from effective axillary treatment

  • Viewpoints
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

We have reviewed the available clinical data on the benefit of axillary treatment in patients with early breast cancer. The results of these studies suggest that perhaps 5–10% of patients are cured by effective axillary treatment. We conclude that effective axillary treatment should still be considered an essential aspect of primary treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Halsted WS: The results of radical operations for the cure of cancer of the breast. Ann Surg 46: 1–19, 1907

    Google Scholar 

  2. Haagensen CD, Stout AD: Carcinoma of the breast: criteria of operability. Ann Surg 118: 859–870, 1932

    Google Scholar 

  3. Huvos AG, Hutter RVP, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173: 44–46, 1971

    PubMed  Google Scholar 

  4. Pickren JW: Significance of occult metastases: a study of breast cancer. Cancer 14: 1266–1271, 1961

    PubMed  Google Scholar 

  5. Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW: Axillary micro- and macro-metastases in breast cancer. Ann Surg 194: 585–591, 1981

    PubMed  Google Scholar 

  6. Fisher B, Montague E: Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 39: 2829–2839, 1977

    Google Scholar 

  7. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynec Obstet 152: 765–772, 1981

    PubMed  Google Scholar 

  8. Fisher B, Slack N, Katrych D, Wolmark N: Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynec Obstet 140: 528–534, 1975

    PubMed  Google Scholar 

  9. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Cancer 41: 1170–1178, 1978

    PubMed  Google Scholar 

  10. Boag JW, Haybittle JL, Fowler JF, Emery EW: The number of patients required in a clinical trial. Brit J Radiol 44: 122–125, 1971

    PubMed  Google Scholar 

  11. Hayward J: The surgeon's role in primary breast cancer. Breast Cancer Res Treat 1: 27–32, 1981

    PubMed  Google Scholar 

  12. Langlands AO, Prescott RJ, Hamilton T: A clinical trial in the management of operable breast cancer. Brit J Surg 67: 170–174, 1980

    PubMed  Google Scholar 

  13. Cancer Research Campaign Working Party: Cancer Research Campaign trial for early breast cancer. Lancet II (8185): 55–60, 1980

    Google Scholar 

  14. Haagensen CD: Diseases of the Breast. Revised 2nd Ed. WB Saunders, Philadelphia, 1971

    Google Scholar 

  15. Auchincloss H: Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg 158: 37–46, 1963

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Therapy, Harvard Medical School, Joint Center for Radiation Therapy, 50 Binney Street, MA 02115, Boston, USA

    Jay R. Harris

  2. Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, USA

    Robert T. Osteen

Authors
  1. Jay R. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert T. Osteen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, J.R., Osteen, R.T. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Tr 5, 17–21 (1985). https://doi.org/10.1007/BF01807645

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807645

Keywords

Search

Navigation